Siemens Healthineers AG (SHL BE) stock market data APIs
€44.5534
0(0%)
as of December 19, 2025
Try our APIs with
free plan!
Siemens Healthineers AG Financial Data Overview
Price chart is built with
Anychart
Prev. Close
44.5534
Open
44.5534
High
44.5534
Low
44.5534
52 wk Range
40.41-57.04
Market Cap
76 282 M
Dividends (Yield)
0.0182
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Siemens Healthineers AG data using free add-ons & libraries
Get Siemens Healthineers AG Fundamental Data
Siemens Healthineers AG Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Siemens Healthineers AG News
New
ALZpath and Siemens Healthineers Sign Licensing Agreement to Advance Global Access to Blood-Based Alzheimer's Disease Diagnostic Testing
Siemens Healthineers will utilize ALZpath's high-performing, proprietary pTau217 antibody in its growing test menu for its Atellica analyzers to enable IVD testing for Alzheimer's disease CARLSBAD, ...
What The Recent Analyst Revisions Mean For Siemens Healthineers Valuation Narrative
Siemens Healthineers has seen its fair value estimate nudged down from €57.67 to €56.99 as analysts fine tune their models to reflect slightly softer revenue growth assumptions of 5.36% easing to ...
Siemens Healthineers (XTRA:SHL): Assessing Valuation After a Year of Share Price Weakness
Siemens Healthineers (XTRA:SHL) has been grinding through a weak share price patch, with the stock down about 19% over the past year, even as revenue and profit continue to edge higher. See our lates...
Telix and Varian Announce Strategic Theranostics-EBRT Clinical Collaboration
MELBOURNE, Australia and PALO ALTO, Calif., Dec. 11, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces a strategic clinical collaboration with Varian,...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
